Valeant Rejected Takeda Bid

Published on: 

May 27, 2016.

Reuters reports that Valeant Pharmaceuticals rejected a joint takeover offer from Japan's Takeda and TPG Capital Management this spring.

The offer was reportedly made a few weeks before Joseph Papa took over as Valeant's new chief executive in April.


More on the story here.